Analytic reviews: Cardiac surgery as a cause of acute kidney injury: Pathogenesis and potential therapies

Journal of Intensive Care Medicine

Volumn 23, Issue 1, 2008, Pages 3-18

  Rosner, Mitchell H ^a   Portilla, Didier ^b   Okusa, Mark D ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Acute kidney injury; Anti inflammatory; Cardiopulmonary bypass surgery; Therapy

Indexed keywords

ACETYLCYSTEINE; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2 RECEPTOR; ADENOSINE A2 RECEPTOR AGONIST; ANTIINFLAMMATORY AGENT; ATRIAL NATRIURETIC FACTOR; BETA 2 MICROGLOBULIN; DEXAMETHASONE; DIURETIC AGENT; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; FENOLDOPAM; FIBRIC ACID DERIVATIVE; FUROSEMIDE; INTERLEUKIN 1; LOOP DIURETIC AGENT; MANNITOL; NATRIURETIC FACTOR; PENTOXIFYLLINE; PEXELIZUMAB; PHOSPHODIESTERASE INHIBITOR; RECOMBINANT ATRIAL NATRIURETIC FACTOR; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; SPHINGOSINE 1 PHOSPHATE; THEOPHYLLINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACUTE DISEASE; CARDIOPULMONARY BYPASS; DIALYSIS; HEART SURGERY; HEMODYNAMICS; HIGH RISK PATIENT; HUMAN; INFLAMMATION; KIDNEY INJURY; LOW DRUG DOSE; MORBIDITY; MORTALITY; PATHOGENESIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RENAL PROTECTION; REVIEW; RISK FACTOR; KIDNEY DISEASE;

ACUTE DISEASE; CARDIOPULMONARY BYPASS; HUMANS; KIDNEY DISEASES; RISK FACTORS;

EID: 38349057895     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066607309998     Document Type: Review

References (161)

1. Lillehei CW Historical development of cardiopulmonary bypass in Minnesota. In: Gravlee GP, Davis RF, Kurusz M, Utley JR, eds. Cardiopulmonary Bypass: Principles and Practice. 2 nd ed. Philadelphia: Lippincott, Williams & Wilkins ; 2000: 3-21.
2. Conlon PJ, Stafford-Smith M., White WD, et al. Acute renal failure following cardiac surgery. Nephrol Dial Transplant. 199 ; 14: 1158-1162.
3. Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A., Herskowitz A., Mangano DT Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes and hospital resource utilization. Ann Intern Med. 1998 ; 128: 194-203.
4. Abel RM, Buckley MJ, Austen WG, Barnett GO, Beck CH Jr, Fischer JE Etiology, incidence and prognosis of renal failure following cardiac operations: results of a prospective analysis of 500 consecutive patients. J Thorac Cardiovasc Surg. 1976 ; 71: 323-333.
5. Gailiunas P. Jr, Chawla R., Lazarus JM, Cohn L., Sanders J., Merrill JP Acute renal failure following cardiac operations. J Thorac Cardiovasc Surg. 1980 ; 79: 241-243.
6. Ostermann ME, Taube D., Morgan CJ, Evans TW Acute renal failure following cardiopulmonary bypass: a changing picture. Intensive Care Med. 2000 ; 26: 565-571.
7. Andersson LG, Ekroth R., Bratteby LE, et al. Acute renal failure after coronary surgery: a study of incidence and risk factors in 2009 consecutive patients. J Thorac Cardiovasc Surg. 1993 ; 41: 237-241.
8. Zanardo G., Michielon P., Paccagnella A., et al. Acute renal failure in the patient undergoing cardiac operation: prevalence, mortality rate, and main risk factors. J Thorac Cardiovasc Surg. 1994 ; 107: 1489-1495.
9. Mangos GJ, Brown MA, Chan YA, et al. Acute renal failure following cardiac surgery: incidents, outcomes and risk factors. Aust N Z J Med. 1995 ; 25: 284-289.
10. Antunes PE, Prieto D., Ferrao de Oliveira J., Antunes MJ Renal dysfunction alter myocardial revascularization. Eur J Cardiothorac Surg. 2004 ; 25: 597-604.
11. Yeboah ED, Petrie A., Pead JL Acute renal failure and open heart surgery. Br Med J. 1972 ; 1: 415-418.
12. Bhat JG, Gluck MC, Lowenstein J., Baldwin DS Renal failure after open heart surgery. Ann Int Med. 1976 ; 84: 677-682.
13. Hilberman M., Myers BD, Carrie BJ, Derby G., Jamison RL, Stinson EB Acute renal failure following cardiac surgery. J Thorac Cardiovasc Surg. 1979 ; 77: 880-888.
14. Corwin HL, Sprague SM, DeLaria GA, Norusis MJ Acute renal failure associated with cardiac operations: a case-control study. J Thorac Cardiovasc Surg. 1989 ; 98: 1107-1112.
15. Schmitt H., Riehl J., Boseilla A., et al. Acute renal failure following cardiac surgery: pre- and perioperative clinical features. Contrib Nephrol. 1991 ; 93: 98-104.
16. Chertow GM, Levy EM, Hammermeister KE, Grover F., Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med. 1998 ; 104: 343-348.
17. Bellomo R., Ronco C., Kellum JA, Mehta RL, Palevsky P. Acute renal failure: definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004 ;8: R204-R212.
18. Abraham VS, Swain JA Cardiopulmonary bypass and the kidney. In: Gravlee GP, Davis RF, Kurusz M, Utley JR, eds. Cardiopulmonary Bypass: Principles and Practice. 2 nd ed. Philadelphia: Lippincott, Williams & Wilkins ; 2000: 382-391.
19. Grayson AD, Khater M., Jackson M., Fox MA Valvular heart operation is an independent risk factor for acute renal failure. Ann Thorac Surg. 2003 ; 75: 1829-1835.
20. Lassnigg A., Schmidlin D., Mouhieddine M., et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol. 2004 ; 15: 1597-1605.
21. Thakar CV, Worley S., Arrigain S., Yared J-P., Paganini EP Influence of renal dysfunction on mortality after cardiac surgery: modifying effect of preoperative renal function. Kidney Int. 2005 ; 67: 1112-1119.
22. Loef BG, Epema AH, Smilde TB, et al. Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. J Am Soc Nephrol. 2005 ; 16: 195-200.
23. Lok CE, Austin PC, Wanh H., Tu JV Impact of renal insufficiency on short- and long-term outcomes after cardiac surgery. Am Heart J. 2004 ; 148: 430-438.
24. Liano F., Pascual J. Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Kidney Int. 1996 ; 50: 811-818.
25. Thakar CV, Yared JP, Worley S., Cotman K., Paganini EP Renal dysfunction and serious infections after open-heart surgery. Kidney Int. 2003 ; 64: 239-246.
26. Chertow GM, Lazarus JM, Christiansen CL, et al. Preoperative renal risk stratification. Circulation. 1997 ; 95: 878-884.
27. Fortescue EB, Bates DW, Chertow GM Predicting acute renal failure after coronary bypass surgery: cross-validation of two risk-stratification algorithms. Kidney Int. 2000 ; 57: 2594-2602.
28. Frost L., Pedersen RS, Lund O., Hansen OK, Hansen HE Prognosis and risk factors in acute, dialysis-requiring renal failure after open-heart surgery. Scand J Thorac Cardiovasc Surg. 1991 ; 25: 161-166.
29. Thakar CV, Liangos O., Yared JP, et al. ARF after open-heart surgery: influence of gender and race. Am J Kidney Dis. 2003 ; 41: 742-751.
30. Thakar CV, Liangos O., Yared J-P., Nelson DA, Hariachar S., Paganini EP Predicting acute renal failure after cardiac surgery: validation and re-definition of a risk stratification algorithm. Hemodial Int. 2003 ; 7: 143-147.
31. Thakar CV, Arrigain S., Worley S., Yared J-P., Paganini EP A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol. 2005 ; 16: 162-168.
32. Slogoff S., Reul GJ, Keats AS, et al. Role of perfusion pressure and flow in major organ dysfunction after cardiopulmonary bypass. Ann Thorac Surg. 1990 ; 50: 911-918.
33. Tuttle KR, Worrall NK, Dahlstrom LR, Nandagopal R., Kausz AT, Davis CL Predictors of ARF after cardiac surgical procedures. Am J Kidney Dis. 2003 ; 41: 76-83.
34. Fischer UM, Weissenberger WK, Warters RD, Geissler HJ, Allen SJ, Mehlhorn U. Impact of cardiopulmonary bypass management on postcardiac surgery renal function. Perfusion. 2002 ; 17: 401-406.
35. Abramov D., Tamariz M., Serrick CI, et al. The influence of cardiopulmonary bypass flow characteristics on the clinical outcome of 1820 coronary bypass patients. Can J Cardiol. 2003 ; 19: 237-243.
36. Urzua J., Troncoso S., Bugedo G., et al. Renal function and cardiopulmonary bypass: effect of perfusion pressure. J Cardiothorac Vasc Anesth. 1992 ; 6: 299-303.
37. Provenchere S., Plantefeve G., Hufnagel G., et al. Renal dysfunction after cardiac surgery with normothermic cardiopulmonary bypass: incidence, risk factors and effect on clinical outcome. Anesth Analg. 2003 ; 96: 1258-1264.
38. The Warm Heart Investigators. Randomized trial of normothermic versus hypothermic coronary artery bypass surgery. Lancet. 1994 ; 343: 559-563.
39. Cook DJ Changing temperature management for cardiopulmonary bypass. Anesth Analg. 1999 ; 88: 12541271.
40. Magee MJ, Edgerton JR Beating heart coronary artery bypass: operative strategy and technique. Sem Thorac Cardiovasc Surg. 2003 ; 15: 83-91.
41. Loef BG, Epema AH, Navis G., Ebels T., van Oeveren W., Henning RH Off-pump coronary revascularization attenuates transient renal damage compared with on-pump coronary revascularization. Chest. 2002 ; 121: 1190-1194.
42. Ascione R., Lloyd CT, Underwood, et al. On-pump versus off-pump coronary revascularization: evaluation of renal function. Ann Thorac Surg. 1999 ; 68: 493-498.
43. Schwann NM, Horrow JC, Strong MD, Chamchad D., Guerraty A., Wechsler AS Does off-pump coronary artery bypass reduce the incidence of clinically evident renal dysfunction after multivessel myocardial revascularization? Anesth Analg. 2004 ; 99: 959-964.
44. Beauford RB, Saunders CR, Niemeier LA, et al. Is off-pump revascularization better for patients with non-dialysis-dependent renal insufficiency? Heart Surg Forum. 2004 ; 7: E141 - E146.
45. Gamboso MG, Phillips-Bute B., Landolfo KP, Newman MF, Stafford-Smith M. Off-pump versus on-pump coronary artery bypass surgery and post-operative renal dysfunction. Anesth Analg. 2000 ; 91: 1080-1084.
46. Stallwood MI, Grayson AD, Mills K., Scawn ND Acute renal failure in coronary artery bypass surgery: independent effect of cardiopulmonary bypass. Ann Thorac Surg. 2004 ; 77: 968-972.
47. Wijeysundera DN, Beattie WS, Djaiana G., et al. Off-pump coronary artery surgery for reducing mortality and morbidity: meta-analysis of randomized and observational studies. J Am Coll Cardiol. 2005 ; 46: 872-882.
48. Hix JK, Thakar CV, Katz EM, et al. Effect of off-pump coronary artery bypass graft surgery on postoperative acute kidney injury and mortality. Crit Care Med. 2006 ; 34: 2979-2983.
49. Messmer K. Hemodilution. Surg Clin North Am. 1975 ; 55: 659-678.
50. Shah D., Corson J., Karmody A., Leather R. Effects of isovolemic hemodilution on abdominal aortic aneurysmectomy in high risk patients. Ann Vasc Surg. 1986 ; 1: 50-54.
51. Swaminathan M., Phillips-Bute BG, Conlon PJ, Smith PK, Newman MF, Stafford-Smith M. The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary artery bypass surgery. Ann Thorac Surg. 2003 ; 76: 784-792.
52. Karkouti K., Beattie WS, Wijeysundera DN, et al. Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery. J Thorac Cardiovasc Surg. 2005 ; 129: 391-400.
53. Habib RH, Zacharias A., Schwann TA, et al. Role of hemodilutional anemia and transfusion during cardiopulmonary bypass in renal injury after coronary revascularization: implications on operative outcome. Crit Care Med. 2005 ; 33: 1749-1756.
54. Chertow GM, Lazarus JM, Christiansen CL, et al. Preoperative renal risk stratification. Circulation. 1997 ; 95: 878-884.
55. Eriksen BO, Hoff KRS, Solberg S. Prediction of acute renal failure after cardiac surgery: retrospective cross-validation of a clinical algorithm. Nephrol Dial Transplant. 2003 ; 18: 77-81.
56. Sheridan AM, Bonventre JV Cell biology and molecular mechanisms of injury in ischemic acute renal failure. Curr Opin Nephrol Hypertens. 2000 ; 9: 427-434.
57. Molitoris BA Transitioning to therapy in ischemic acute renal failure. J Am Soc Nephrol. 2003 ; 14: 265-267.
58. Sutton TA, Fisher CJ, Molitoris BA Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int. 2002 ; 62: 1539-1549.
59. Conger JD Vascular alterations in acute renal failure: roles in initiation and maintenance. In: Molitoris BA, Finn WF, eds. Acute Renal Failure: A Companion to Brenner and Rector's The Kidney. Philadelphia: Saunders ; 2001: 13-29.
60. Okusa MD The inflammatory cascade in acute ischemic renal failure. Nephron. 2002 ; 90: 133-138.
61. Trof RJ, Di Maggo F., Leemreis J., Groeneveld AB Biomarkers of acute renal injury and renal failure. Shock. 2006 ; 26: 245-253.
62. Chou SY, Porush JG, Faubert PF Renal medullary circulation: hormonal control. Kidney Int. 1990 ; 37: 1-13.
63. Lequier LL, Nikaidoh H., Leonard SR, et al. Preoperative and postoperative endotoxemia in children with congenital heart disease. Chest. 2000 ; 117: 1706-1712.
64. Bennet-Guerrero E., Ayuso L., Hamilton-Davies C., et al. Relationship of pre-operative anti-endotoxin core antibodies and adverse outcomes following cardiac surgery. JAMA. 1997 ; 277: 646-650.
65. Nilsson L., Kulander L., Nystrom SO, et al. Endotoxins in cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1990 ; 100: 777-780.
66. Riddington DW, Venkatesh B., Boivin CM, et al. Intestinal permeability, gastric intramucosal pH, and systemic endotoxemia in patients undergoing cardiopulmonary bypass. JAMA. 1996 ; 275: 1007-1012.
67. Levine B., Kalman J., Mayer L., et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990 ; 323: 236-241.
68. Torre-Amione G., Kapadia S., Benedict C., et al. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol. 1996 ; 27: 1201-1206.
69. Parolari A., Alamanni F., Gherli T., et al. Cardiopulmonary bypass and oxygen consumption: oxygen delivery and hemodynamics. Ann Thorac Surg. 1999 ; 67: 1320-1327.
70. Kirklin JW, Barratt-Boyes BG Cardiac Surgery. 2 nd ed. New York: Churchill Livingstone ; 1993.
71. Kurusz M., Davis RF, Conti VR Conduct of cardiopulmonary bypass. In: Gravlee GP, Davis RF, Kurusz M, Utley JR, eds. Cardiopulmonary Bypass: Principles and Practice. 2 nd ed. Philadelphia: Lippincott, Williams & Wilkins ; 2000: 549-578.
72. Rudy LW, Heymann MA, Edmunds H. Distribution of systemic blood flow during cardiopulmonary bypass. J Appl Physiol. 1973 ; 34: 194-200.
73. Harris EA, Seelye ER, Barratt-Boyes BG On the availability of oxygen to the body during cardiopulmonary bypass in man. Br J Anaesth. 1974 ; 46: 425-431.
74. Urzua J., Troncoso S., Bugedo G., et al. Renal function and cardiopulmonary bypass: effect of perfusion pressure. J Cardiovasc Vasc Anesth. 1992 ; 6: 299-303.
75. Gold JP, Charlson ME, Williams-Russo P., et al. Improvement of outcomes after coronary artery bypass: a randomized trial comparing intraoperative high versus low mean arterial pressure. J Thorac Cardiovasc Surg. 1995 ; 110: 1302-1314.
76. Kelleher SP, Robinette JB, Conger JD Sympathetic nervous system in the loss of autoregulation in acute renal failure. Am J Physiol. 1984 ; 246: F379 - F386.
77. Cremer J., Martin M., Redl H., et al. Systemic inflammatory response after cardiac operations. Ann Thorac Surg. 1996 ; 61: 1714-1720.
78. Taylor K. SIRS: the systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg. 1996 ; 61: 1607-1608.
79. Czerny M., Baumer H., Kilo J., et al. Inflammatory response and myocardial injury following coronary artery bypass grafting with or without cardiopulmonary bypass. Eur J Cardiothorac Surg. 2000 ; 17: 737-742.
80. Fransen E., Maessen J., Dentener M., et al. Systemic inflammation present in patients undergoing CABG without extracorporeal circulation. Chest. 1998 ; 113: 1290-1295.
81. Asimakopoulos G., Taylor KM Effects of cardiopulmonary bypass on leukocyte and endothelial adhesion molecules. Ann Thorac Surg. 1998 ; 66: 2135-2144.
82. Galinanes M., Watson C., Trivedi U., et al. Differential patterns of neutrophil adhesion molecules during cardiopulmonary bypass in humans. Circulation. 1996 ; 94 (suppl 2). 364-369.
83. Zilla P., Fasol R., Groscurth P., et al. Blood platelets in cardiopulmonary bypass operations. J Thorac Cardiovasc Surg. 1989 ; 97: 379-388.
84. Haga Y., Hatori N., Yoshizu H., et al. Granulocyte super-oxide anion and elastase release during cardiopulmonary bypass. Artif Organs. 1993 ; 17: 837-842.
85. Faymonville ME, Pincemail J., Duchateau J., et al. Myeloperoxidase and elastase as markers of leukocyte activation during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1991 ; 102: 309-317.
86. Frering B., Philip I., Dehous M., et al. Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1994 ; 108: 642-647.
87. Paparella D., Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment: an update. Eur J Cardiothorac Surg. 2002 ; 21: 232-244.
88. Musial J., Niewiarowski S., Hershock D., et al. Loss of fibrinogen receptors from the platelet surface during simulated extracorporeal circulation. J Lab Clin Med. 1985 ; 105: 514-526.
89. Hornick P., Taylor KM Immune and inflammatory responses after cardiopulmonary bypass. In: Gravlee GP, Davis RF, Kurusz M, Utley JR, eds. Cardiopulmonary Bypass: Principles and Practice. 2 nd ed. Philadelphia: Lippincott, Williams & Wilkins ; 2000: 303-320.
90. Campbell DJ, Dixon B., Kladis A., et al. Activation of the kallikrein-kinin system by cardiopulmonary bypass in humans. Am J Physiol Regul Integr Comp Physiol. 2001 ; 281: R1059 R1070.
91. Moreau ME, Garbacki N., Molinaro G., et al. The kallikrein-kinin system: current and future pharmacological targets. J Pharmacol Sci. 2005 ; 99: 6-38.
92. Kirklin JK, Westaby S., Blackstone EH, et al. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1983 ; 86: 845-857.
93. Burne-Taney MJ, Rabb H. The role of adhesion molecules and T cells in ischemic renal injury. Curr Opin Nephrol Hypertens. 2003 ; 12: 85-90.
94. Sheridan AM, Bonventre JV Cell biology and molecular mechanisms of injury in ischemic acute renal failure. Curr Opin Nephrol Hypertens. 2000 ; 9: 427-434.
95. Donnahoo KK, Meng X., Ayala A., et al. Early kidney TNF-expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion. Am J Physiol. 1999 ; 277: R922 - R929.
96. McCoy RN, Hill KE, Ayon MA, et al. Oxidant stress following renal ischemia: changes in the glutathione redox ratio. Kidney Int. 1988 ; 33: 812-817.
97. Tennenberg SD, Clardy CW, Bailey WW, et al. Complement activation and lung permeability during cardiopulmonary bypass. Ann Thorac Surg. 1990 ; 50: 597-601.
98. Jansen NJ, van-Oeveren W., Gu YJ, et al. Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass. Ann Thorac Surg. 1992 ; 54: 744-747.
99. Blauth J. Macroemboli and microemboli during cardiopulmonary bypass. Ann Thorac Surg. 1995 ; 59: 1300-1303.
100. van der Linden J., Casimir-Ahn H. When do cerebral emboli appear during open heart operations? A transcranial Doppler study. Ann Thorac Surg. 1991 ; 51: 237-241.
101. Barbut D., Hinton RB, Szatrowski TP, et al. Cerebral emboli detected during bypass surgery are associated with clamp removal. Stroke. 1994 ; 25: 2398-2402.
102. Sreeram GM, Grocott HP, White WD, Newman MF, Stafford-Smith M. Transcranial Doppler emboli count predicts rise in creatinine after coronary artery bypass graft surgery. J Cardiovasc Vasc Anesth. 2004 ; 18: 548-551.
103. Bidstrup BP, Royston D., Sapsford RN, et al. Reduction in blood loss and blood use after cardiopulmonary bypass with high-dose aprotinin. J Thorac Cardiovasc Surg. 1989 ; 97: 364-372.
104. Runstom R., Grime JS, Maltby P., et al. Observations on the early renal uptake and later tubular metabolism of radiolabeled aprotinin (Trasylol) in man: theoretical and practical considerations. Clin Sci (Colch). 1993 ; 84: 231-241.
105. Kramer HJ, Moch T., von Sicherer L., Dusing R. Effects of aprotinin on renal function and urinary prostaglandin excretion in conscious rats after acute salt loading. Clin Sci (Colch). 1979 ; 56: 547-555.
106. Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med. 2006 ; 354: 353-365.
107. Kincaid EH, Ashburn DA, Hoyle JR, et al. Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery? Ann Thorac Surg. 2005 ; 80: 1388-1393.
108. Moat NE, Evans TE, Quinlan GJ, et al. Chelatable iron and copper can be released from extracorporeally circulated blood during cardiopulmonary bypass. Fed Eur Biochem Soc. 1993 ; 328: 103-106.
109. Gutteridge JMC. Iron promoters of the Fenton reaction and lipid peroxidation can be released from hemoglobin by peroxides. Fed Eur Biochem Soc Lett. 1986 ; 201: 291-295.
110. Flaherty JT, Weisfeldt ML Reperfusion injury. Free Radic Biol Med. 1988 ; 5: 409-419.
111. Gutteridge JMC, Quinlan GJ Antioxidant protection against organic and inorganic oxygen radicals by normal human plasma: the important primary role for iron-binding and iron-oxidizing proteins. Biochim Biophys Acta. 1992 ; 1159: 248-254.
112. Pepper JR, Mumby S., Gutteridge JMC. Sequential oxidative damage and changes in iron-binding and iron-oxidizing plasma antioxidants during cardiopulmonary bypass surgery. Free Radic Res. 1994 ; 21: 377-385.
113. Pepper JR, Mumby S., Gutteridge JMC. Blood cardioplegia increases plasma iron overload and thiol levels during cardiopulmonary bypass. Ann Thorac Surg. 1995 ; 60: 1735-1740.
114. Menasche P., Antebi H., Alcindor LG, et al. Iron chelation by deferoxamine inhibits lipid peroxidation during cardiopulmonary bypass in humans. Circulation. 1990 ; 82: IV390 - IV396.
115. Woo EB, Tang AT, el-Gamel A., et al. Dopamine therapy for patients at risk of renal dysfunction following cardiac surgery: science or fiction? Eur J Cardiothorac Surg. 2002 ; 22: 106-111.
116. Tang AT, El-Gamel A., Keevil B., et al. The effect of 'renal-dose' dopamine on renal tubular function following cardiac surgery: assessed by measuring retinol binding protein (RBP). Eur J Cardiothorac Surg. 1999 ; 15: 717-721.
117. Denton MD, Chertow GM, Brady HR " Renal-dose" dopamine for the treatment of acute renal failure: scientific rationale, experimental studies and clinical trials. Kidney Int. 1996 ; 50: 4-14.
118. Friedrich JO, Adhikari N., Herridge MS, Beyene J. Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med. 2005 ; 142: 510-520.
119. Stone GW, McCullough PA, Tumlin JA, et al, for the CONTRAST Investigators. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA. 2003 ; 290: 2284-2291.
120. Ranucci M., Soro G., Barzaghi N., et al. Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients. Ann Thorac Surg. 2004 ; 78: 1332-1337.
121. Caimmi PP, Pagani L., Micalizzi E., et al. Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2003 ; 17: 491-494.
122. Garwood S., Swamidoss CP, Davis EA, Samson L., Hines RL A case series of low-dose fenoldopam in seventy cardiac surgical patients at increased risk of renal dysfunction. J Cardiothorac Vasc Anesth. 2003 ; 17: 17-21.
123. Bove T., Landoni G., Calabro MG, et al. Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial. Circulation. 2005 ; 111: 3230-3236.
124. Brienza N., Malcangi V., Dalfino L., et al. A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients. Crit Care Med. 2006 ; 34: 707-714.
125. www.flowmedica.com
126. Kramer BK, Preuner J., Ebenburger A., et al. Lack of renoprotective effect of theophylline during aortocoronary bypass surgery. Nephrol Dial Transplant. 2002 ; 17: 910-915.
127. Light DB, Schwiebert EM, Karlson KH, Stanton BA Atrial natriuretic peptide inhibits a cation channel in renal inner medullary collecting duct cells. Science. 1989 ; 243: 383-385.
128. Sward K., Valsson F., Odencrants P., et al. Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebo controlled trial. Crit Care Med. 2004 ; 32: 1310-1315.
129. Jarnberg PO Renal protection strategies in the perioperative period. Best Pract Res Clin Anaesthesiol. 2004 ; 18: 645-660.
130. Lassnigg A., Donner E., Grubhofer G., et al. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol. 2000 ; 11: 97-104.
131. Lombardi R., Ferreiro A., Servetto C. Renal function after cardiac surgery: adverse effect of furosemide. Ren Fail. 2003 ; 25: 775-786.
132. Engelman RM, Gouge TH, Smith SJ, et al. The effect of diuretics on renal hemodynamics during cardiopulmonary bypass. J Surg Res. 1974 ; 16: 268-276.
133. Mehta RL, Pascual MT, Soroko S., Chertow GM Diuretics, mortality and nonrecovery of renal function in acute renal failure. JAMA. 2002 ; 288: 2547-2552.
134. Cooper JR, Giesecke NM Hemodilution and priming solutions. In: Gravlee GP, Davis RF, Kurusz M, Utley JR, eds. Cardiopulmonary Bypass: Principles and Practice. 2ns ed. Philadelphia: Lippincott, Williams & Wilkins ; 2000: 186-196.
135. Rigden SP, Dillon MJ, Kind PR, et al. The beneficial effect of mannitol on postoperative renal function in children undergoing cardiopulmonary bypass surgery. Clin Nephrol. 1984 ; 21: 148-151.
136. Fisher AR, Jones P., Barlow P., et al. The influence of mannitol on renal function during and after open-heart surgery. Perfusion. 1998 ; 13: 181-186.
137. Ip-Yam PC, Murphy S., Baines M., Fox MA, Desmond MJ, Innes PA Renal function and proteinuria after cardiopulmonary bypass: the effects of temperature and mannitol. Anesth Analg. 1994 ; 78: 842-847.
138. Carcoana OV, Mathew JP, Davis E., et al. Mannitol and dopamine in patients undergoing cardiopulmonary bypass: a randomized clinical trial. Anesth Analg. 2003 ; 97: 1222-1229.
139. Sirivella S., Gielchinsky I., Parsonnet V. Mannitol, furosemide, and dopamine infusion in postoperative renal failure complicating cardiac surgery. Ann Thorac Surg. 2000 ; 69: 501-506.
140. Sullivan GW, Carper HT, Novick WJ Jr, Mandell GL Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifylline. Infect Immun. 1988 ; 56: 1722-1729.
141. Cagli K., Ulas MM, Ozisik K., et al. The intraoperative effect of pentoxifylline on the inflammatory process and leukocytes in cardiac surgery patients undergoing cardiopulmonary bypass. Perfusion. 2005 ; 20: 45-51.
142. Zhang M., Xu YJ, Saini HK, Turan B., Liu PP, Dhalla NS Pentoxifylline attenuates cardiac dysfunction and reduces TNF-{alpha}level in the ischemic-reperfused heart. Am J Physiol Heart Circ Physiol. 2005 ; 289: H832 - H839.
143. Boldt J., Brosch C., Piper SN, Suttner S., Lehmann A., Werling C. Influence of prophylactic use of pentoxifylline on postoperative organ function in elderly cardiac surgery patients. Crit Care Med. 2001 ; 29: 952-958.
144. Loef BG, Henning RH, Epema AH, et al. Effect of dexamethasone on perioperative renal function impairment during cardiac surgery with cardiopulmonary bypass. Br J Anaesth. 2004 ; 93: 793-798.
145. Shernan SK, Fitch JC, Nussmeier NA, et al, and the Pexelizumab Study Investigators. Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass. Ann Thorac Surg. 2004 ; 77: 942-949.
146. Sucu N., Cinel I., Unlu A., et al. N-acetylcysteine for preventing pump-induced oxidoinflammatory response during cardiopulmonary bypass. Surg Today. 2004 ; 34: 237-242.
147. Tossios P., Bloch W., Huebner A., et al. N-acetylcysteine prevents reactive oxygen species-mediated myocardial stress in patients undergoing cardiac surgery: results of a randomized, double-blind, placebo-controlled clinical trial. Thorac Cardiovasc Surg. 2003 ; 126: 1513-1520.
148. Kshirsagar AV, Poole C., Mottl A., et al. N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials. J Am Soc Nephrol. 2004 ; 15: 761-769
149. Burns KE, Chu MW, Novick RJ, et al. Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing CABG surgery: a randomized controlled trial. JAMA. 2005 ; 294: 342-349.
150. Jo SK, Rosner MH, Okusa MD Pharmacological treatment of acute kidney injury: why drugs have not worked and what is on the horizon. Clin J Am Soc Nephrol. 2007 ; 2: 356-365.
151. Awad AS, Ye H., Huang L., et al. Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney. Am J Physiol Renal Physiol. 2006 ; 290: F1516 - F1524.
152. Li L., Okusa MD Blocking the immune response in ischemic acute kidney injury: the role of adenosine 2A agonists. Nat Clin Pract Nephrol. 2006 ; 2: 432-444.
153. Myles PS, Hunt JO, Holdgaard HO, et al. Clonidine and cardiac surgery: haemodynamic and metabolic effects, myocardial ischaemia and recovery. Anaesth Intensive Care. 1999 ; 27: 137-147.
154. Kulka PJ, Tryba M., Zenz M. Preoperative alpha2-adrenergic receptor agonists prevent the deterioration of renal function after cardiac surgery: results of a randomized, controlled trial. Crit Care Med. 1996 ; 24: 947-952.
155. Fansa I., Gol M., Nisanoglu V., et al. Does diltiazem inhibit the inflammatory response in cardiopulmonary bypass? Med Sci Monit. 2003 ; 9: P130 - P136.
156. Chanda J., Canver CC Reversal of preexisting vasospasm in coronary artery conduits. Ann Thorac Surg. 2001 ; 72: 476-480.
157. Bergman AS, Odar-Cederlof I., Westman L., et al. Diltiazem infusion for renal protection in cardiac surgical patients with preexisting renal dysfunction. J Cardiothorac Vasc Anesth. 2002 ; 16: 294-299.
158. Piper SN, Kumle B., Maleck WH, et al. Diltiazem may preserve renal tubular integrity after cardiac surgery. Can J Anaesth. 2003 ; 50: 285-292.
159. Young EW, Diab A., Kirsh MM Intravenous diltiazem and acute renal failure after cardiac operations. Ann Thorac Surg. 1998 ; 65: 1316-1319.
160. Amar D., Fleisher M. Diltiazem treatment does not alter renal function after thoracic surgery. Chest. 2001 ; 119: 1476-1479.
161. Durmaz I., Yagdi T., Calkavur T., et al. Prophylactic dialysis in patients with renal dysfunction undergoing on-pump coronary artery bypass surgery. Ann Thorac Surg. 2003 ; 75: 859-864.